Chemed Corp

490.74+7.27+1.50%Vol 40.07K1Y Perf 6.12%
Aug 12th, 2022 16:00 DELAYED
BID196.19 ASK784.73
Open484.25 Previous Close483.47
Pre-Market- After-Market490.74
 - -  - -%
Target Price
588.00 
Analyst Rating
Strong Buy 1.33
Potential %
19.82 
Finscreener Ranking
     41.90
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     40.15
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★+     56.36
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
     32.08
Price Range Ratio 52W %
64.10 
Earnings Rating
Neutral
Market Cap7.31B 
Earnings Date
27th Jul 2022
Alpha0.01 Standard Deviation0.06
Beta0.53 

Today's Price Range

483.02493.55

52W Range

403.00539.87

5 Year PE Ratio Range

20.7057.70

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
2.61%
1 Month
-0.65%
3 Months
-1.64%
6 Months
3.85%
1 Year
6.12%
3 Years
14.54%
5 Years
155.75%
10 Years
698.19%

TickerPriceChg.Chg.%
CHE490.747.27001.50
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
36.90
17.10
19.80
15.80
12.95
RevenueValueIndustryS&P 500US Markets
2.14B
143.68
5.18
6.22
DividendsValueIndustryS&P 500US Markets
0.31
1.52
5.51
6.40
Payout ratio6.00
Earnings HistoryEstimateReportedSurprise %
Q02 20224.784.841.26
Q01 20224.494.796.68
Q04 20215.065.253.75
Q03 20214.465.0613.45
Q02 20214.454.603.37
Q01 20214.204.445.71
Q04 20205.145.13-0.19
Q03 20203.994.8621.80
Earnings Per EndEstimateRevision %Trend
6/2022 QR4.78-1.44Negative
9/2022 QR4.76-2.06Negative
12/2022 FY19.09-1.04Negative
12/2023 FY21.27-0.19Negative
Next Report Date-
Estimated EPS Next Report4.78
Estimates Count3
EPS Growth Next 5 Years %8.50
Volume Overview
Volume40.07K
Shares Outstanding14.90K
Shares Float12.83M
Trades Count2.91K
Dollar Volume19.65M
Avg. Volume56.96K
Avg. Weekly Volume44.00K
Avg. Monthly Volume63.34K
Avg. Quarterly Volume63.55K

Chemed Corp (NYSE: CHE) stock closed at 490.74 per share at the end of the most recent trading day (a 1.5% change compared to the prior day closing price) with a volume of 40.07K shares and market capitalization of 7.31B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 15544 people. Chemed Corp CEO is Kevin J. Mcnamara.

The one-year performance of Chemed Corp stock is 6.12%, while year-to-date (YTD) performance is -7.24%. CHE stock has a five-year performance of 155.75%. Its 52-week range is between 403 and 539.87, which gives CHE stock a 52-week price range ratio of 64.10%

Chemed Corp currently has a PE ratio of 26.90, a price-to-book (PB) ratio of 10.53, a price-to-sale (PS) ratio of 3.37, a price to cashflow ratio of 22.30, a PEG ratio of 2.32, a ROA of 20.56%, a ROC of 28.62% and a ROE of 35.64%. The company’s profit margin is 12.95%, its EBITDA margin is 19.80%, and its revenue ttm is $2.14 Billion , which makes it $143.68 revenue per share.

Of the last four earnings reports from Chemed Corp, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $4.78 for the next earnings report. Chemed Corp’s next earnings report date is -.

The consensus rating of Wall Street analysts for Chemed Corp is Strong Buy (1.33), with a target price of $588, which is +19.82% compared to the current price. The earnings rating for Chemed Corp stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Chemed Corp has a dividend yield of 0.31% with a dividend per share of $1.52 and a payout ratio of 6.00%.

Chemed Corp has a Buy technical analysis rating based on Technical Indicators (ADX : 19.34, ATR14 : 10.36, CCI20 : -8.48, Chaikin Money Flow : 0.01, MACD : -1.39, Money Flow Index : 46.30, ROC : -6.36, RSI : 55.98, STOCH (14,3) : 37.70, STOCH RSI : 1.00, UO : 49.94, Williams %R : -62.30), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Chemed Corp in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.33

Chemed Corp

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. It also manufactures products and equipment used to provide these services. Chemed generates the majority of its revenue from business in the United States.

CEO: Kevin J. Mcnamara

Telephone: +1 513 762-6690

Address: 255 East Fifth Street, Cincinnati 45202-4726, OH, US

Number of employees: 15 544

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

63%38%

Bearish Bullish

64%36%

Bearish Bullish

58%42%


News

Stocktwits